Palladium Energy (Palladium), a leading power developer in the United States, today announced the closing of a $66 million ...

Mara Holdings and Soluna Holdings are underrated players in the AI data center boom.

More than 6 million Americans are living with Alzheimer's disease, a staggering number that's expected to double within the next 30 years. But there are signs of optimism in the fight against ...

The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials. On the heels of newly FDA-approved drugs Aduhelm (aducanumab) in 2021 and ...

The "Diabetic Retinopathy - Pipeline Insight, 2026" report highlights growth opportunities with over 50 companies and 55 drugs in development across varied stages. Key prospects include advancing anti ...

- License and development agreement with Janssen leverages Pipeline’s expertise in precision neuroregeneration and Janssen’s development experience across nervous system disorders SAN DIEGO--(BUSINESS ...

More organizations are waking up to the fact that a robust leadership pipeline is vital to their sustained success. Companies such as Procter & Gamble, Google, Ernst & Young, General Electric, and ...

Fail fast, fail cheap is a common clich in drug development. Studies project that anywhere from 4060% of potential drugs candidates fail in development due to absorption, distribution, metabolism, ...

Since its experimental Silicon Valley origins in the ‘80s, sales development continues its growth as a strategic go-to-market (GTM) operation. Faced with inadequate pipeline and a trepidatious ...

More than 6 million Americans are living with Alzheimer’s disease, a staggering number that’s expected to double within the next 30 years. But there are signs of optimism in the fight against ...